Repligen (NASDAQ:RGEN) Raised to Buy at Wall Street Zen
Wall Street Zen upgraded shares of Repligen (NASDAQ:RGEN – Free Report) from a hold rating to a buy rating in a report issued on Saturday. Several other brokerages have also issued reports on RGEN. HC Wainwright restated a “buy” rating and set a $180.00 target price on shares of Repligen in a research report on […]
Wall Street Zen upgraded shares of Repligen (NASDAQ:RGEN – Free Report) from a hold rating to a buy rating in a report issued on Saturday. Several other brokerages have also issued reports on RGEN. HC Wainwright restated a “buy” rating and set a $180.00 target price on shares of Repligen in a research report on […]
